Investors Encouraged to Inquire About Securities Class Action Investigation Against GeneDx Holdings Corp.
ByAinvest
Sunday, Aug 17, 2025 9:49 pm ET1min read
WGS--
The investigation stems from a report published by Grizzly Research on February 5, 2025, titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. Following this report, GeneDx's stock fell by 6.7% on February 5, 2025 [1].
Investors who purchased GeneDx securities may be entitled to compensation without incurring any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. Interested investors can join the prospective class action by visiting [https://rosenlegal.com/submit-form/?case_id=40333](https://rosenlegal.com/submit-form/?case_id=40333) or by contacting Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].
The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation. The firm has recovered hundreds of millions of dollars for investors and has been ranked in the top 4 each year since 2013. In 2019 alone, the firm secured over $438 million for investors [3].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250813dc51052/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation-wgs
[2] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c51dfdc8bf72c
[3] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302529374.html
GeneDx Holdings Corp. is being investigated for potentially misleading business information to investors. Shareholders may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, visit https://rosenlegal.com/submit-form/?case_id=40333 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com. The Rosen Law Firm is representing investors globally and has a track record of success in securities class actions and shareholder derivative litigation.
GeneDx Holdings Corp. (NASDAQ: WGS) investors are being encouraged to inquire about a potential securities class action investigation. The Rosen Law Firm, a globally recognized investor rights law firm, is investigating allegations that GeneDx may have issued materially misleading business information to the investing public.The investigation stems from a report published by Grizzly Research on February 5, 2025, titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report alleged that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. Following this report, GeneDx's stock fell by 6.7% on February 5, 2025 [1].
Investors who purchased GeneDx securities may be entitled to compensation without incurring any out-of-pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. Interested investors can join the prospective class action by visiting [https://rosenlegal.com/submit-form/?case_id=40333](https://rosenlegal.com/submit-form/?case_id=40333) or by contacting Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].
The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation. The firm has recovered hundreds of millions of dollars for investors and has been ranked in the top 4 each year since 2013. In 2019 alone, the firm secured over $438 million for investors [3].
References:
[1] https://www.morningstar.com/news/pr-newswire/20250813dc51052/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation-wgs
[2] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c51dfdc8bf72c
[3] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302529374.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet